|
|
PLoS Pathog. 2008 May; 4(5): e1000068. Published online 2008 May 16. doi: 10.1371/journal.ppat.1000068. | PMCID: PMC2364663 |
Copyright Lovegrove et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Parasite Burden and CD36-Mediated Sequestration Are Determinants of Acute Lung Injury in an Experimental Malaria Model Fiona E. Lovegrove,1,2 Sina A. Gharib,3 Lourdes Peña-Castillo,4 Samir N. Patel,2 John T. Ruzinski,3 Timothy R. Hughes,2,4,5 W. Conrad Liles,#1,2,6 and Kevin C. Kain#1,2,6* 1Institute of Medical Science, Department of Medicine, University of Toronto, Toronto, Ontario, Canada 2McLaughlin-Rotman Centre for Global Health, McLaughlin Centre for Molecular Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada 3Department of Medicine, University of Washington, Seattle, Washington, United States of America 4Center for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada 5Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario, Canada 6Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada James Kazura, Editor Case Western Reserve University, United States of America Received October 16, 2007; Accepted April 14, 2008. Although acute lung injury (ALI) is a common complication of severe malaria, little is known about the underlying molecular basis of lung dysfunction. Animal models have provided powerful insights into the pathogenesis of severe malaria syndromes such as cerebral malaria (CM); however, no model of malaria-induced lung injury has been definitively established. This study used bronchoalveolar lavage (BAL), histopathology and gene expression analysis to examine the development of ALI in mice infected with Plasmodium berghei ANKA (PbA). BAL fluid of PbA-infected C57BL/6 mice revealed a significant increase in IgM and total protein prior to the development of CM, indicating disruption of the alveolar–capillary membrane barrier—the physiological hallmark of ALI. In contrast to sepsis-induced ALI, BAL fluid cell counts remained constant with no infiltration of neutrophils. Histopathology showed septal inflammation without cellular transmigration into the alveolar spaces. Microarray analysis of lung tissue from PbA-infected mice identified a significant up-regulation of expressed genes associated with the gene ontology categories of defense and immune response. Severity of malaria-induced ALI varied in a panel of inbred mouse strains, and development of ALI correlated with peripheral parasite burden but not CM susceptibility. Cd36−/− mice, which have decreased parasite lung sequestration, were relatively protected from ALI. In summary, parasite burden and CD36-mediated sequestration in the lung are primary determinants of ALI in experimental murine malaria. Furthermore, differential susceptibility of mouse strains to malaria-induced ALI and CM suggests that distinct genetic determinants may regulate susceptibility to these two important causes of malaria-associated morbidity and mortality. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) can occur in adult malaria infections with a case fatality rate of 70%–100%. ALI and ARDS are characterized by protein-rich fluid in the lungs, with reduced gas exchange, and in malaria, often accompany high parasite levels and severe or cerebral disease. In this work we have examined lung physiology, pathology and genomics in mouse malaria—Plasmodium berghei ANKA—to show that mice develop malaria-induced ALI. Infected mice have proteinaceous fluid in their lungs, have a migration of inflammatory cells from the blood into the lung walls, and express immune response–related genes. We also found that severity of ALI depended on high parasite levels, both overall and specifically in the lung tissue, but was not consistent with whether the mice developed cerebral malaria. ALI due to Plasmodium berghei ANKA infection models prominent characteristics of human malaria-associated ALI, and we have better defined this model of malaria ALI so it may be used to further explore disease mechanisms and eventual treatment. Pulmonary complications have been reported in malaria caused by infection with Plasmodium falciparum, Plasmodium vivax and Plasmodium ovale [1], [2]. Pulmonary edema, with features of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS), occurs in approximately 20% of severe malaria patients [3], often in association with cerebral malaria (CM), acute renal failure and high parasitemia [3], [4], [5], [6], [7], [8]. ARDS in adults is an important predictor of mortality in malaria, and is associated with a greater than 70% case fatality rate [3]. Although ALI and ARDS are rare in the pediatric population [9], respiratory distress accompanying severe metabolic acidosis is common in children and predicts poor outcome [10]. While pulmonary involvement is a recognized complication of malaria infection, little is currently known about its pathogenesis [11]. A spectrum of severity exists with respiratory involvement in malaria infection. Cough is a common presentation in uncomplicated malaria due to P. falciparum, P. vivax and P. ovale infections [1], [2]. Reduced gas transfer and impaired alveolar-capillary membrane function have been correlated with severe disease [2]. Patients can rapidly progress to respiratory failure, either in association with severe disease or shortly after treatment [9]. Studies suggest that this post-treatment lung injury may be associated with prolonged alveolar-capillary inflammation [1], [12]. Lung ultrastructural studies from individuals with fatal P. falciparum-induced lung injury indicate endothelial cell cytoplasmic swelling and edema in the lung interstitium, with monocytes and parasitized erythrocytes (PE) adherent within the capillaries [13], [14]. Additionally, septal or interstitial edema occurs in regions of PE adherence [15]. Lung endothelium likely plays an important role in malaria lung injury, in response to PE adhesion, parasite-induced inflammation (for example, by malaria GPI) and leukocyte adhesion. In vitro, P. falciparum PEs have been shown to promote oxidative stress [16], and activate caspases leading to apoptosis in human primary lung endothelial cells [16]. Both P. falciparum PEs and GPI induce up-regulation of endothelial inflammatory markers, including intracellular cell adhesion molecule-1 (ICAM-1; NP_000192) and interleukin-6 (IL-6; NP_000591) [17], [18], [19]. An increase in cell adhesion molecules may further enhance leukocyte and PE adhesion, contributing to localized endothelial damage. Although the murine malaria model of P. berghei ANKA (PbA) has primarily been used to study CM [20], pulmonary pathology has also been described in some previously published studies that employed this model of severe malaria [20], [21], [22], [23], [24], [25], [26]. Lung histopathology of PbA-infected mice has been reported to show endothelial adhesion of pigment-containing monocytes and neutrophils, and a “septal pneumonitis” [24]. Immunoglobulins, complement 3, complement 4 and parasite antigens in the lung interstitium and alveoli were detected by immunohistochemistry one to three hours prior to death in CM-susceptible mice [22]. Studies have also demonstrated increased pulmonary vascular permeability in PbA infection [20], [23], [25], which may be influenced by CD11a-positive neutrophil and monocyte sequestration [23]. Additionally, PbA parasites sequester in lung tissue in a CD36-dependent manner [27], and the lung may be a preferential site of PbA biosynthesis and/or proliferation [28]. Collectively, these data suggest that significant lung pathology occurs in PbA infection and contributes to malaria-associated morbidity and mortality. Since relatively little is known about lung injury in malarial disease, a mouse model could lead to pathophysiological insights with potential relevance to human disease. We hypothesized that ALI would occur in the PbA mouse model and would be mediated by parasite sequestration in the lung. Similar to severe malarial syndromes in human disease, we show that ALI develops in PbA infection, and is influenced by both parasite burden and local sequestration. PbA-infected mice develop ALI characterized by alveolar-capillary membrane barrier disruption In order to characterize PbA infection as a model of malaria lung injury, bronchoalveolar lavage (BAL) was performed on C57Bl/6 mice 1–2 days prior to the development of CM symptoms and death and the BAL fluid (BALF) was examined for protein content. Increased levels of total protein, and more specifically IgM, in the BALF are indicative of alveolar-capillary membrane barrier disruption and are hallmarks of ALI [29], [30], [31]. Levels of total protein were significantly elevated at day 7 post-infection (, one-way ANOVA with Bonferoni's multiple comparison correction, Day 7 vs. Day 0: p<0.01). Furthermore, IgM was increased at both Day 6 and Day 7 compared to baseline (, p<0.001). These data showed that a disruption of the alveolar-capillary membrane barrier and ALI occur as a result of PbA infection. ALI caused by PbA infection is associated with increased production of pro-inflammatory cytokines in peripheral blood but not in alveolar spaces To examine pulmonary inflammation induced during PbA infection, a panel of cytokines and chemokines were examined in plasma, lung tissue homogenate and BALF. PbA failed to induce proinflammatory cytokine production in the alveoli of infected mice, as measured in the BALF (). In contrast, proinflammatory cytokine production was increased both locally (in lung tissue) and peripherally (in plasma) during the course of PbA infection. Tumor necrosis factor (TNF; NP_038721, ), macrophage inflammatory protein-2 (MIP-2; NP_033166, ), interleukin-10 (IL-10; NP_034678, ), IL-6 ( NP_112445, ), keratinocyte-derived cytokine (KC or murine IL-8; NP_032202, ) and interferon-γ (IFN-γ; NP_032363, ) levels were all significantly increased in plasma at day 6 compared to baseline (Kruskal-Wallis test with Dunn's multiple comparison test; p<0.05: TNF, IFN-γ; p<0.01: IL-10, KC; p<0.001: MIP-2, IL-6). Lung homogenate levels of IL-6 and KC were significantly increased at Day 6 (p<0.01 and p<0.05, respectively) and tissue levels of MIP-2 and IFN-γ were significantly elevated at both days 6 and 7 compared to day 0 (D6 vs. D0: p<0.01; D7 vs. D0: p<0.05). Overall, both systemic and local tissue inflammation occur as a result of PbA infection, however, cytokine and chemokines are produced in the plasma and lung interstitium rather than in the alveolar spaces. Lung tissue of PbA-infected mice shows interstitial inflammation but no cellular infiltrates in the alveoli To further characterize PbA-induced ALI, both alveolar cell counts and lung histology were examined for pathological changes. No cellular infiltration into the alveoli occurred over the course of PbA infection, but rather BALF cell counts were decreased at day 7 compared to day 6 (, Kruskal-Wallis test with Dunn's multiple comparison test: p<0.05). Histopathological analysis revealed interstitial pulmonary inflammation at day 6 post-infection, with increased numbers of inflammatory cells in the alveolar septae (, upper panel). However, consistent with the BALF cell count data, the alveolar spaces were free of inflammatory cells. By day 7 post-infection the lungs remained inflamed, with no alveolar cellular infiltration. However, lung architecture was lost in some areas and interstitial hemorrhages were seen in individual animals (, upper panel). Additionally, microscopic analysis of BAL cells showed few changes in cell type (, lower panel). Interestingly, erythrocytes, and rarely PEs, could be found in the alveoli of PbA-infected mice. To summarize, these data indicate that ALI occurs in the PbA model of severe malaria, characterized by pulmonary edema and interstitial inflammation initiated via an “inside-out” mechanism that fails to induce transmigration of inflammatory cells to the alveolar spaces. Genes associated with defense and immune response gene ontology (GO) categories are up-regulated in PbA-induced ALI To examine mechanisms underlying the pathophysiology of PbA-induced ALI, expression microarray analysis of mouse lung tissue was performed. Three hundred and eighty differentially expressed genes were identified in the lungs of PbA infected C57BL/6 mice at day 6, compared to uninfected controls, at a false discovery rate of 1% using Exploratory Differential Gene Expression (EDGE) analysis [32]. Functional analysis of the differentially up-regulated genes revealed significant enrichment in the gene ontology (GO) categories of host defense and immune response, response to stress, and ribosomal activity, whereas down-regulated genes were enriched in metabolism pathways and ATPase activity ( Table 1). | Table 1GO categories over-represented in the differentially expressed genes from the PbA model of ALI |
Because defense and immune response GO categories were highly enriched in the PbA model of ALI, differentially expressed genes within this functional category were further explored using network analysis. In addition to the differentially expressed genes identified using the EDGE analysis, cytokines significantly increased in lung homogenate (MIP2, IL-6, KC, and IFN-γ; ) were included in the analysis, for a total of 27 gene products. The resultant gene-gene interaction network (or interactome), created from previously identified gene product interactions, consisted of 21 genes (). Many of these genes were up-regulated cytokines and chemokines. Additionally, the structure of this interactome was dependent upon three hubs, or nodes of high interconnectivity: namely, IFN-γ ( NM_008337), TNF ( NM_013693) and IL-6 ( NM_031168). Susceptibility to ALI in PbA infection does not correlate with cerebral malaria susceptibility To investigate whether genetic determinants regulating susceptibility to CM in the PbA model correlate with ALI, the responses of two pairs of CM-resistant and CM-susceptible in-bred mouse strains infected with PbA were compared. At day 6 post-infection, despite their divergent outcome, C57BL/6 (CM-susceptible) and BALB/c (CM-resistant mice) have equivalently elevated BALF IgM concentrations () and parasitemia (), although this study is limited by its small sample size (N  = 6). However, CM-hyper-susceptible 129SV/J mice developed significantly higher BALF IgM levels than CM-resistant AKRJ mice (, Mann-Whitney test: p = 0.0012). This coincided with the 129SV/J developing significantly higher parasitemia than the AKRJ mice (, Mann-Whitney U test p = 0.0022). Therefore, in this model, genetic resistance to CM for example in BALB/c mice does not necessarily confer resistance to ALI. ALI in PbA infection is correlated with peripheral parasite burden Since no association was found between the development of CM and ALI, the effect of parasite burden on the development of ALI was examined. Mice with higher parasitemias were more likely to show correspondingly high levels of IgM and total protein in the BALF ( Table 2). This observation led to the hypothesis that the extent of lung injury may be influenced by peripheral parasitemia, which likely reflects local parasite burden in the lung. Because diverse genetic factors influence infection in the different in-bred strains, this question was addressed using escalating parasite inocula in order to induce a spectrum of parasitemia in ALI-susceptible C57BL/6. Consistent with this hypothesis, mice that received a higher inoculum of PbA had increased concentrations of BALF IgM at day 6 post-infection (; Kruskal-Wallis test with Dunn's multiple comparison test, 1×10 6 vs. 1×10 5 PE: p<0.05) corresponding with elevated circulating parasitemias (; Kruskal-Wallis test with Dunn's multiple comparison test, 1×10 6 vs. 1×10 5 PE: p<0.05). Parasitemia was positively correlated with BALF IgM log concentration (; r 2= 0.73). These findings suggest that ALI is influenced by parasite burden and that increasing levels of circulating infected erythrocytes result in increasing levels of ALI. | Table 2Summary of the correlation between peripheral parasitemia and BAL IgM or total protein levels in all in-bred strains tested at Day 6 post-infection (*p<0.05) |
ALI induced by PbA infection is attenuated in Cd36−/− mice A high peripheral parasite burden may not only stimulate proinflammatory processes but also increase the number of parasites available for sequestration in vital organs, including the lung. P. berghei parasites preferentially bind in the lungs of infected mice in a CD36-dependent manner (CD36; NP_031669) [27]. Given their reduced lung parasite burden, we hypothesized that Cd36−/− ( Cd36; NM_007643) mice would be expected to be protected from ALI caused by P. berghei infection. Additionally, CD36 is a receptor for thrombospondin-1 (Thbs-1; NP_035710), which was identified in the defense response interactome (). Thbs-1 ( NM_011580) was up-regulated in the lungs of mice at day 6 post infection, compared to uninfected animals. This observation was confirmed using quantitative real-time RT-PCR analysis of an independent PbA infection (mean normalized copy number±standard deviation: Day 6 1193.3±199.2, Day 0 545.6±11.9, 2-tailed t-test with welch's correction p<0.03). Similar to previously published work, PbA-infected Cd36−/− mice were not protected from death secondary to CM (data not shown). However, Cd36−/− mice developed significantly less ALI during PbA infection compared to their wild type counterparts, as measured by BALF IgM concentration (, -tailed t-test, p<0.0001), despite having an equivalent parasitemia (). In summary, ALI induced by experimental murine malaria was CD36-dependent. This study provides a detailed analysis of ALI that occurs in experimental murine malaria, which may provide an informative tool to study ALI and ARDS associated with human malaria infection. Mice infected with PbA develop septal inflammation and disruption of the alveolar-capillary membrane barrier, leading to a proteinaceous non-cardiogenic pulmonary edema, dependent on parasite burden and CD36. Interestingly, susceptibility to ALI does not necessarily correlate with CM development in genetically in-bred mouse strains. While all CM-susceptible strains tested developed ALI, there was differential susceptibility of CM-resistant strains to ALI, for example BALB/c develop ALI whereas others did not (AKR/J). These data suggest that ALI occurs via a mechanism distinct from the pathogenesis of CM in the PbA model. ALI in experimental murine PbA malaria may, at least partially, represent a clinically relevant model of ALI seen in individuals with severe human malaria, since both share similar histopathology features, parasite sequestration in the lung capillaries and alveolar-capillary membrane barrier disruption leading to pulmonary edema. Lung histology from both PbA and P. falciparum infections shows an edematous interstitium with leukocyte infiltration [13]. PEs and leukocytes sequester in the pulmonary microvasculature in human malaria infections, as demonstrated by both ultrastructural studies [13], [14], [15] and a reduced pulmonary capillary vascular component volume [2], [12]. Additionally, hemorrhage is a classic feature of non-malarial human ALI/ARDS [29], [33] and histopathological reports on malaria-induced ALI indicate that focal alveolar hemorrhages occur in humans [34], [35], similar to those observed in the PbA model. Progressive alveolar-capillary dysfunction has been reported in individuals with malaria immediately following appropriate antimicrobial therapy [2], [12]. This post-treatment lung damage has been attributed to the host inflammatory response, and it appears that pulmonary complications in human malaria result from a combination of PE sequestration, and the corresponding host inflammatory response to parasite burden. As in human malaria, ALI in the PbA model is partially mediated by parasite burden and sequestration ( & ), but also likely occurs as a response to parasite-driven inflammatory responses. Indeed, work using an anti- P. falciparum GPI vaccine in the PbA model showed markedly reduced pulmonary edema in immunized versus sham-immunized animals [26]. As with any animal model of disease, there are limitations to the correlations that can be drawn to human disease, especially since limited studies have examined ALI in human malaria infection. It is not possible to comment on how the BAL findings from this model relate to human malaria, because these studies have not been performed and obtaining BAL samples from severe malaria patients, especially in a field setting, may present challenges. Additionally, while certain in-bred mouse strains show differential susceptibility to PbA-induced ALI and CM–BALB/c mice develop ALI but are resistant to CM–this may not necessarily reflect what occurs in human malaria. Although case reports and other studies have demonstrated that respiratory involvement and ALI can occur in non-cerebral malaria [1], [2], [4], [12], other studies have shown that lung parasite burden parallels that in the brain [34] and that ALI commonly occurs in conjunction with CM [3], [8], [34], [35]. This study examined transcriptional profiles from the lungs of PbA infected mice. The defense/immune response interactome () is structured around three hubs of high interconnectivity–TNF, IFN-γ and IL-6, all of which play significant roles in host pro-inflammatory responses to malaria [36], [37], [38]. The functional stability of genetic networks is highly dependent on nodes of high interactivity [39], indicating they may play a pivotal role in the transcriptional response to PbA-induced ALI and thus may be promising therapeutic targets. TNF has been well-established as a key mediator of ALI [40], [41], [42], which is also likely the case in PbA, since TNF levels were significantly increased in the lung tissue of infected mice. However, since IFN-γ, TNF and IL-6 are involved in multiple biological processes in PbA infection, it may be possible to more effectively modulate these key hubs by targeting a molecule or pathway shared by them, such as THBS-1 (). THBS-1 was of particular interest among the interactome because it binds and signals primarily via CD36 ( NP_000063) [43], [44]. THBS-1 ( NP_003237) has also been identified as an cellular receptor for PE adhesion [45], and additionally, soluble THBS-1 binds to PEs, augmenting adhesion to endothelial cells via CD36 under physiological flow conditions [46], [47]. The upregulation of thbs-1 expression could play an important role in PbA-induced ALI by increasing CD36-mediated cytoadherance in the lung, especially since CD36 is a primary receptor for PEs in the pulmonary vascular endothelium [27]. Although CD36 deficiency does not affect CM development and survival in the PbA model [27], our work demonstrates that Cd36−/− mice develop significantly less ALI compared to wild-type controls. This finding suggests that malaria-induced ALI occurs via a CD36-dependent pathogenic mechanism. These findings may appear to conflict with previous work by our group, which has argued that CD36 may be beneficial in the immune response to malaria via its role as a receptor for non-opsonic phagocytosis of PEs by macrophages [48], [49], [50], [51]. Recent studies, using chimeric mice expressing CD36 only on hematopoietic cells, showed that CD36 on myeloid cells (i.e. the hematopoeitic compartment) but not on endothelial cells (the non-hematopoeitic compartment) conferred protection to CM in the PbA model [52]. However, there is conflicting evidence that PEs that bind CD36 are associated with severe disease. Parasites isolated from severe malaria patients in Thailand were shown to preferentially bind ICAM-1 on lung endothelium in vitro compared to those from uncomplicated patients [53]. Similarly among children with severe malaria in Africa, parasite binding to CD36 was inversely related to disease severity [54], but another study found that CD36 binding was equivalent between parasitized erythrocytes derived from CM patients or community controls [55]. However none of these studies specifically examined parasite isolates from patients displaying symptoms of ALI. Additionally, polymorphisms in CD36, and CD36 deficiency, exist as natural variants in malaria endemic regions, including Asia [56] and Africa [57]. CD36 polymorphisms have been associated with both increased [58] and decreased susceptibility to CM [59]. Moreover, a specific non-sense mutation in CD36 was shown to be significantly associated with protection from respiratory distress in African children [60]. These studies examined different polymorphisms, which may reflect differential protein function or expression in different cell types. If CD36 mutations do confer susceptibility to cerebral malaria [53], these mutations may be maintained in human populations through selection pressure of another prevalent infection other than malaria, or perhaps even by resistance to malaria-associated ALI. Additional studies are required to clarify the association between CD36 polymorphisms and severe malaria including ALI. Taken together, the available data suggest a dual role for CD36 in malaria infection. Specifically, as a pattern recognition receptor on myeloid cell lineages, CD36 may contribute to innate immune response and parasite clearance but at high parasite density, endothelial cell CD36 may also play a role, at least in the mouse model, in the development of tissue injury at sites such as the lung. Mice and parasites Animal use protocols were reviewed and approved by the Faculty of Medicine Advisory Committee on Animal Services at the University of Toronto and all experiments were conducted according to the animal ethics guidelines of the University of Toronto. C57Bl/6 and BALB/c mice were obtained from Charles River Laboratories (Senneville QC), and 129SV/J and AKR/J were purchased from Jackson Laboratories (Bar Harbor ME). CD36−/− mice (on a C57Bl/6 background, a gift from Maria Febbraio (New York NY)) were bred and maintained at the University of Toronto animal facility. Mice were 8–12 weeks of age and groups were matched by sex. Each experiment was performed twice, with 6–10 mice per group, as outlined in individual figure legends. Cryopreserved PbA (MR4, Vannassas MA) was thawed and passaged through naïve C57Bl/6 donor mice until parasitemia in the passage animals reached approximately 10%. On day 0, experimental mice were infected by intraperitoneal injection with freshly isolated PbA. Male mice were inoculated with 5×105 PE and females with 1×106 PE, inocula that reproducibly show 100% mortality in C57BL/6 mice. Parasitemia was monitored daily after Day 3 using thin blood smears stained with modified Giemsa (Protocol Hema 3 Stain Set; Sigma, Oakville ON). Bronchoalveolar lavage fluid (BALF) analysis At Day 6 or 7, infected mice and uninfected controls were euthanized using isofluorane and BALF of both lungs was obtained by instillation and aspiration of three 0.5 ml aliquots of Dubecco's Phosphate Buffered Saline (PBS; Gibco/Invitrogen, Burlington ON) [33]. The BALF was spun at 800×g at 4°C for 5 min, and the supernatant was removed and stored at −80°C for further protein analysis. The cell pellet was resuspended in 1 ml ice-cold PBS. Total cell numbers were determined using a hemocytometer and differential cell counts were determined by cytocentrifugation and modified Giemsa staining. BALF concentrations of MIP-2, mouse keratinocyte-derived cytokine (KC or IL-8), IL-1α ( NP_034684), IL-6, IL-10, TNF-α , (that measures TNF and LT-α) and IFN-γ were determined by multiplex immunoassay (Luminex 100) using cytokine-specific bead kits according to the manufacturer's protocols (R&D Systems, Minneapolis MN). TNF-α levels in lung homogenates were confirmed using a standard sandwich ELISA according to the manufacturer's protocol (eBioscience, San Diego CA). BALF total protein concentration was measured using a BCA protein assay (Sigma), and BALF IgM concentration was determined by ELISA (Bethyl Laboratories, Montgomery TX). Lung homogenate analysis Lungs were excised, weighed and homogenized in 2ml PBS/0.5g lung tissue for 30 sec. using a ULTRA -TURRAX® disperser (IKA, Wilmington NC). Homogenates were stored at −80°C for further cytokine analysis. Cytokine concentrations were measured as described above. Lung histology Lungs were fixed for histology at 20cm H2O with 4% paraformaldehyde buffered in PBS. After fixation, the lungs were embedded in paraffin, cut into 4-µm sections, and stained with hematoxylin and eosin (H&E). RNA isolation and microarray hybridization Lungs were excised immediately following euthanasia, snap-frozen in liquid nitrogen and stored at −80°C until use. Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer's instructions, and mRNA was purified using an Oligo-dT cellulose column (NEB, Mississauga, ON) as described previously [61]. cDNA with incorporated 5-(3-aminoallyl)-2′deoxyuridine-5′-triphosphate (AAdUTP; Sigma, Oakville ON) was reverse-transcribed from 1–2 µg mRNA. Purified cDNA was coupled with N-hydroxysuccinimide esters of Cy3 or Cy5 (GE Lifesciences, Baie d'Urfe QC). Cy3 and Cy5-labeled cDNA pairs and Agilent control spots were added to a final volume of 0.5ml hybridization buffer (1 M NaCl, 0.5% sodium sarcosine, 50 mM methyl ethane sulfonate (MES), pH 6.5, 33% formamide and 40 µg salmon sperm DNA (Invitrogen)). Hybridizations were performed in Agilent hybridization (Agilent, Palo Alto CA) chambers at 42°C with rotation for 18–24 hours. Slides were washed in 6×SSPE, 0.005% sarcosine, followed by 0.06×SSPE, allowed to dry and scanned with a 4000A microarray scanner (Axon Instruments, Union City CA). TIFF images were quantified with GenePix (Axon Instruments). Variance stabilizing normalization [62] and loess smoothing were applied in Bioconductor [63] and the data were transformed to log2 scale. Each array was hybridized with cDNA transcribed from an RNA pool of 5 C57BL/6 mice per timepoint (Day 0 and 6) and technical replicates (dye-swap) experiments were performed for both time points. Microarray Data Analysis Probe mapping was performed as previously described [28] and a total of 9724 unique mouse genes, annotated using the Entrez Gene database, were included in the analysis. Since RNA was pooled from whole lung homogenates and replication was limited to dye-switching experiments, a statistical framework developed for the analysis of single cDNA microarray experiments–Exploratory Differential Gene Expression (EDGE)–was utilized [32]. This program was implemented in the R software environment ( www.r-project.org) to determine statistical significance in each microarray experiment. The problem of multiple hypothesis testing was addressed using false discovery analysis based on Q-values [64]. A gene was deemed significantly differentially expressed if its Q-value was ≤0.01 in at least one of the dye-switching experiments and the direction of change (i.e., up or down-regulation relative to uninfected controls) was consistent in both experiments. Gene Ontology (GO) Analysis Functional annotation of the genes was obtained from Gene Ontology Consortium's database [65], based on their respective molecular function, biological process, or cellular component. Enriched functional categories within differentially expressed genes were determined using the Expression Analysis Systematic Explorer (EASE) algorithm [66]. A variant of the one-tailed Fisher exact probability test based on the hypergeometric distribution was used to calculate P-values. Generated P-values indicated whether a given GO process is over-represented compared to what would be expected by random sampling. Multiple hypothesis testing was addressed by performing permutation analysis (n = 1000) and selecting a false discovery rate cutoff of ≤0.001. Gene Network Analysis A gene-gene interaction network was created by mining gene product interactions from the following databases: Ingenuity [67], Adriadne [68], and Human Protein Reference Database [69]. These knowledge bases have been manually and computationally compiled through extensive literature searches. Molecular relationships consisting of direct physical, transcriptional, and enzymatic interactions among gene products serve as the basis for creating genetic networks from gene or protein expression data. Quantitative real-time RT-PCR cDNA was synthesized from 0.5 µg of mRNA using Superscript II reverse transcriptase with Oligo (dT) 12-18 primers (Invitrogen). Serial dilutions of mouse genomic DNA were used as standards [70]. gDNA standards or cDNA were added to the qPCR reaction containing 1× Power Sybr Green Master Mix (Applied Biosystems) and 0.5 µM primers in a final volume of 10 µl. qPCR was performed using the ABI Prism ® 7900HT Sequence Detection System (Applied Biosystems). Copy numbers were normalized to 3 mouse housekeeping genes– Hprt, Sdha, and Ywhaz [71]. Forward (fwd) and reverse (rvs) primer sequences are as follows: Thbs1-fwd: TGT GGA CTT CAG CGG TAC CTT CTT; Thbs1-rvs: GGA CTG GGT GAC TTG TTT CCA CAT; Hprt-fwd: GGAGTCCTGTTGATGTTGCCAGTA, Hprt-rvs: GGGACGCAGCAACTGACATTTCTA; Sdha-fwd: TCACGTCTACCTGCAGTTGCATCA, Sdha-rvs: TGACATCCACACCAGCGAAGATCA; Ywhaz-fwd: AGCAGGCAGAGCGATATGATGACA, Ywhaz-rvs: TCCCTGCTCAGTGACAGACTTCAT. The authors would like to thank Dr. T. Moraes (University of Toronto, Toronto, ON) for teaching the BAL technique; Ms. A. Conroy, Dr. M. Hawkes and Dr. C. Finney (University of Toronto) for assistance in performing BAL experiments; and to Dr. G. Downey (National Jewish Medical and Research Center, Denver, CO) for his insightful discussion. Histopathology was performed by the Pathology Research Program at the University Health Network, Toronto ON. 1. Anstey NM, Jacups SP, Cain T, Pearson T, Ziesing PJ, et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis. 2002;185:1326–1334. [PubMed] 2. Maguire GP, Handojo T, Pain MC, Kenangalem E, Price RN, et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J Infect Dis. 2005;192:1966–1974. [PubMed] 3. Aursudkij B, Wilairatana P, Vannaphan S, Walsh DS, Gordeux VR, et al. Pulmonary edema in cerebral malaria patients in Thailand. Southeast Asian J Trop Med Public Health. 1998;29:541–545. [PubMed] 4. Asiedu DK, Sherman CB. Adult respiratory distress syndrome complicating Plasmodium falciparum malaria. Heart Lung. 2000;29:294–297. [PubMed] 5. Rajput R, Singh H, Singh S, Meena, Tiwari UC. Pulmonary manifestations in malaria. J Indian Med Assoc. 2000;98:612–614. [PubMed] 6. Gupta D, Ramanathan RP, Aggarwal AN, Jindal SK. Assessment of factors predicting outcome of acute respiratory distress syndrome in North India. Respirology. 2001;6:125–130. [PubMed] 7. Jindal SK, Aggarwal AN, Gupta D. Adult respiratory distress syndrome in the tropics. Clin Chest Med. 2002;23:445–455. [PubMed] 8. Gachot B, Wolff M, Nissack G, Veber B, Vachon F. Acute lung injury complicating imported Plasmodium falciparum malaria. Chest. 1995;108:746–749. [PubMed] 9. Taylor WR, Canon V, White NJ. Pulmonary manifestations of malaria : recognition and management. Treat Respir Med. 2006;5:419–428. [PubMed] 10. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. Indicators of life-threatening malaria in African children. N Engl J Med. 1995;332:1399–1404. [PubMed] 11. Taylor WR, White NJ. Malaria and the lung. Clin Chest Med. 2002;23:457–468. [PubMed] 12. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis. 2007;195:589–596. [PubMed] 13. Duarte MI, Corbett CE, Boulos M, Amato Neto V. Ultrastructure of the lung in falciparum malaria. Am J Trop Med Hyg. 1985;34:31–35. [PubMed] 14. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol. 1985;119:385–401. [PubMed] 15. Corbett CE, Duarte MI, Lancellotti CL, Silva MA, Andrade Junior HF. Cytoadherence in human falciparum malaria as a cause of respiratory distress. J Trop Med Hyg. 1989;92:112–120. [PubMed] 16. Gimenez F, Barraud de Lagerie S, Fernandez C, Pino P, Mazier D. Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci. 2003;60:1623–1635. [PubMed] 17. Viebig NK, Wulbrand U, Forster R, Andrews KT, Lanzer M, et al. Direct activation of human endothelial cells by Plasmodium falciparum-infected erythrocytes. Infect Immun. 2005;73:3271–3277. [PubMed] 18. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB. Infect Immun. 2006;74:3262–3270. [PubMed] 19. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, et al. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol. 1996;156:1886–1896. [PubMed] 20. Neill AL, Hunt NH. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology. 1992;105 ( Pt 2):165–175. [PubMed] 21. Weiss ML. Immune complexes in the lungs of mice infected with Plasmodium berghei. Isr J Med Sci. 1978;14:655–658. [PubMed] 22. Weiss ML, Kubat K. Plasmodium berghei: a mouse model for the “sudden death” and “malarial lung” syndromes. Exp Parasitol. 1983;56:143–151. [PubMed] 23. Senaldi G, Vesin C, Chang R, Grau GE, Piguet PF. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun. 1994;62:1144–1149. [PubMed] 24. Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, et al. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol. 2000;95:1–7. [PubMed] 25. van der Heyde HC, Bauer P, Sun G, Chang WL, Yin L, et al. Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique. Infect Immun. 2001;69:3460–3465. [PubMed] 26. Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature. 2002;418:785–789. [PubMed] 27. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, Ramesar J, Buscher P, et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A. 2005;102:11468–11473. [PubMed] 28. Lovegrove FE, Pena-Castillo L, Mohammad N, Liles WC, Hughes TR, et al. Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics. 2006;7:295. [PubMed] 29. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349. [PubMed] 30. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1376–1383. [PubMed] 31. Guidot DM, Folkesson HG, Jain L, Sznajder JI, Pittet JF, et al. Integrating acute lung injury and regulation of alveolar fluid clearance. Am J Physiol Lung Cell Mol Physiol. 2006;291:L301–306. [PubMed] 32. Loguinov AV, Mian IS, Vulpe CD. Exploratory differential gene expression analysis in microarray experiments with no or limited replication. Genome Biol. 2004;5:R18. [PubMed] 33. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, et al. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol. 2001;158:153–161. [PubMed] 34. Spitz S. The pathology of acute falciparum malaria. Mil Surg. 1946;99:555–572. 35. Brooks MH, Kiel FW, Sheehy TW, Barry KG. Acute pulmonary edema in falciparum malaria. N Engl J Med. 1968;279:732–737. 36. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999;180:1288–1297. [PubMed] 37. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24:491–499. [PubMed] 38. de Kossodo S, Grau GE. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol. 1993;151:4811–4820. [PubMed] 39. Luscombe NM, Babu MM, Yu H, Snyder M, Teichmann SA, et al. Genomic analysis of regulatory network dynamics reveals large topological changes. Nature. 2004;431:308–312. [PubMed] 40. Ward PA. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci. 1996;796:104–112. [PubMed] 41. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis. 1988;137:1364–1370. [PubMed] 42. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 2004;202:145–156. [PubMed] 43. Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isolation of the thrombospondin membrane receptor. J Clin Invest. 1987;79:1054–1061. [PubMed] 44. Silverstein RL, Baird M, Lo SK, Yesner LM. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J Biol Chem. 1992;267:16607–16612. [PubMed] 45. Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ, Howard RJ, et al. Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature. 1985;318:64–66. [PubMed] 46. Rock EP, Roth EF, Jr, Rojas-Corona RR, Sherwood JA, Nagel RL, et al. Thrombospondin mediates the cytoadherence of Plasmodium falciparum-infected red cells to vascular endothelium in shear flow conditions. Blood. 1988;71:71–75. [PubMed] 47. Siano JP, Grady KK, Millet P, Swerlick RA, Wick TM. Plasmodium falciparum: soluble thrombospondin increases cytoadherence of parasitized erythrocytes to human microvascular endothelium under shear flow conditions. Exp Parasitol. 1997;87:69–72. [PubMed] 48. McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood. 2000;96:3231–3240. [PubMed] 49. Patel SN, Serghides L, Smith TG, Febbraio M, Silverstein RL, et al. CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages. J Infect Dis. 2004;189:204–213. [PubMed] 50. Serghides L, Kain KC. Peroxisome proliferator-activated receptor gamma-retinoid×receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J Immunol. 2001;166:6742–6748. [PubMed] 51. Serghides L, Kain KC. Mechanism of protection induced by vitamin A in falciparum malaria. Lancet. 2002;359:1404–1406. [PubMed] 52. Cunha-Rodrigues M, Portugal S, Febbraio M, Mota MM. Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection. Malar J. 2007;6:32. [PubMed] 53. Traore B, Muanza K, Looareesuwan S, Supavej S, Khusmith S, et al. Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model. Am J Trop Med Hyg. 2000;62:38–44. [PubMed] 54. Rogerson SJ, Tembenu R, Dobano C, Plitt S, Taylor TE, et al. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg. 1999;61:467–472. [PubMed] 55. Newbold C, Warn P, Black G, Berendt A, Craig A, et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg. 1997;57:389–398. [PubMed] 56. Yamamoto N, Ikeda H, Tandon NN, Herman J, Tomiyama Y, et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36). Blood. 1990;76:1698–1703. [PubMed] 57. Curtis BR, Aster RH. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion. 1996;36:331–334. [PubMed] 58. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, et al. Malaria susceptibility and CD36 mutation. Nature. 2000;405:1015–1016. [PubMed] 59. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, et al. CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet. 2003;72:364–374. [PubMed] 60. Pain A, Urban BC, Kai O, Casals-Pascual C, Shafi J, et al. A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet. 2001;357:1502–1503. [PubMed] 61. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, et al. Functional discovery via a compendium of expression profiles. Cell. 2000;102:109–126. [PubMed] 62. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(Suppl 1):S96–104. [PubMed] 63. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80. [PubMed] 64. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440–9445. [PubMed] 65. Gene Ontology Consortium. Creating the gene ontology resource: design and implementation. Genome Res. 2001;11:1425–1433. [PubMed] 66. Hosack DA, Dennis G, Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70. [PubMed] 67. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032–1037. [PubMed] 68. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio–the analysis and navigation of molecular networks. Bioinformatics. 2003;19:2155–2157. [PubMed] 69. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res. 2004;32:D497–501. [PubMed] 70. Yun JJ, Heisler LE, Hwang II, Wilkins O, Lau SK, et al. Genomic DNA functions as a universal external standard in quantitative real-time PCR. Nucleic Acids Res. 2006;34:e85. [PubMed] 71. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034. [PubMed]
|
